Drug intelligence / Profile preview

autologous human mesenchymal cells

Development stage
Unknown
Lead developer
Mesoblast
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intrathecal, Local Injection/implantation Into Affected Tissue[6]
01

Overview

Autologous human mesenchymal cells refer to multipotent stromal (stem) cells that are isolated from a patient's own tissues—most commonly bone marrow or adipose tissue—and expanded in vitro for therapeutic use. These cells can differentiate into various cell types including osteoblasts (bone), chondrocytes (cartilage), myocytes (muscle), and adipocytes (fat). Their primary mechanism of action is believed to be the modulation of immune responses and secretion of trophic factors that promote tissue repair and regeneration. Autologous use minimizes the risk of immune rejection or graft-versus-host disease. Clinical applications under investigation include treatment for Crohn’s disease-related fistulas, multiple sclerosis, degenerative disc disease, amyotrophic lateral sclerosis (ALS), osteoarthritis, infertility, and other conditions involving tissue damage or inflammation[3][4][5][6][7].

Other names
autologous human mesenchymal stem cellsautologous MSCsautologous mesenchymal stromal cells

Beyond the preview

Go deeper on autologous human mesenchymal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous human mesenchymal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call